ArticlePDF Available

The SIC protocol: A seven-step strategy to minimize complications potentially related to the insertion of centrally inserted central catheters

Authors:
  • Global Vascular Access, LLC

Abstract

Insertion of central venous catheters in the cervico-thoracic area is potentially associated with the risk of immediate/early untoward events, some of them negligible (repeated punctures), some relevant (accidental arterial puncture), and some severe (pneumothorax). Furthermore, different strategies adopted during insertion may reduce or increase the incidence of late catheter-related complications (infection, venous thrombosis, dislodgment). This paper describes a standardized protocol (S.I.C.: Safe Insertion of Centrally Inserted Central Catheters) for the systematic application of seven basic beneficial strategies to be adopted during insertion of central venous catheters in the cervico-thoracic region, aiming to minimize immediate, early, or late insertion-related complications. These strategies include: preprocedural evaluation, appropriate aseptic technique, ultrasound guided insertion, intra-procedural assessment of the tip position, adequate protection of the exit site, proper securement of the catheter, and adequate coverage of the exit site.
https://doi.org/10.1177/11297298211036002
The Journal of Vascular Access
1 –6
© The Author(s) 2021
Article reuse guidelines:
sagepub.com/journals-permissions
DOI: 10.1177/11297298211036002
journals.sagepub.com/home/jva
JVA e Journal of
Vascular Access
Introduction
The insertion of Centrally Inserted Central Catheters
(CICC) is a widely used procedure in clinical practice, cur-
rently associated with a decreased risk of complications
than in the past. Many factors have contributed to improve
the safety of this clinical practice, the most important
being the increasingly widespread use of ultrasound (US)
in the different phases of CICC insertion. Ultrasound may
be used for the preliminary assessment of veins, real-time
venipuncture, and immediate detection of possible punc-
ture-related complications (such as tissue hematomas,
intramural hematomas of the vein, pneumothorax, others).
Ultrasound also allows for “tip navigation” (i.e. to verify
the correct direction of the guidewire and/or catheter while
they progress into the vascular system), for “tip location”
(i.e. to assess the central position of the tip), and for the
diagnosis of many late non-infective complications
(fibroblastic sleeve, catheter-related venous thrombosis,
tip migration, others).1–8
Ultrasound is of paramount importance but is not the
unique solution for the reduction of all catheter-related
The SIC protocol: A seven-step
strategy to minimize complications
potentially related to the insertion of
centrally inserted central catheters
Fabrizio Brescia1, Mauro Pittiruti2, Matthew Ostroff3,
Timothy R Spencer4 and Robert B Dawson5
Abstract
Insertion of central venous catheters in the cervico-thoracic area is potentially associated with the risk of immediate/
early untoward events, some of them negligible (repeated punctures), some relevant (accidental arterial puncture), and
some severe (pneumothorax). Furthermore, different strategies adopted during insertion may reduce or increase the
incidence of late catheter-related complications (infection, venous thrombosis, dislodgment). This paper describes a
standardized protocol (S.I.C.: Safe Insertion of Centrally Inserted Central Catheters) for the systematic application of
seven basic beneficial strategies to be adopted during insertion of central venous catheters in the cervico-thoracic region,
aiming to minimize immediate, early, or late insertion-related complications. These strategies include: preprocedural
evaluation, appropriate aseptic technique, ultrasound guided insertion, intra-procedural assessment of the tip position,
adequate protection of the exit site, proper securement of the catheter, and adequate coverage of the exit site.
Keywords
Techniques and procedures, ultrasound guidance, standardized assessment, central venous access, patient safety,
centrally inserted central catheters
Date received: 20 May 2021; accepted: 12 July 2021
1 Unit of Anesthesia and Intensive Care Medicine, Vascular Access
Team, Centro di Riferimento Oncologico di Aviano, IRCCS, Aviano,
Italy
2 Department of Surgery, Fondazione Policlinico Universitario
“A.Gemelli” IRCCS, Rome, Italy
3Saint Joseph’s University Medical Center, Paterson, NJ, USA
4Global Vascular Access, LLC, Scottsdale, AZ, USA
5 Catholic Medical Center – Upper Connecticut Valley Hospital,
Colebrook, NH, USA
Corresponding author:
Fabrizio Brescia, Unit of Anesthesia and Intensive Care Medicine,
Vascular Access Team, Centro di Riferimento Oncologico di Aviano,
IRCCS, Via Gallini 2, Aviano 33081, Italy.
Email: fabriziobrescia@gmail.com
1036002JVA0010.1177/11297298211036002The Journal of Vascular AccessBrescia et al.
editorial2021
Editorial
2 The Journal of Vascular Access 00(0)
complications. Other evidence-based strategies (proper
choice of the exit site, skin antisepsis with 2% chlorhex-
idine in alcohol, maximal barrier precautions, intracavitary
ECG for tip positioning, sutureless securement, others) are
also known to increase the safety and the cost-effective-
ness of the procedure.1–5
An insertion bundle consists of clear recommendations
based on scientific evidence, capable of acting synergisti-
cally to provide maximal safety, positive outcomes, and
cost-effectiveness of a given procedure. When placing a
CICC, the purpose of an insertion bundle is to minimize
any complication directly or indirectly related to the
maneuver (accidental injury, incorrect tip location, arrhyth-
mias, catheter-related venous thrombosis, catheter-related
infections, others).
A similar insertion bundle has already been proposed
for peripherally inserted central catheters (PICCs), the
so-called SIP protocol.9 In the following paragraphs, the
authors will describe a seven-step strategy for minimiz-
ing insertion-related complications associated with
CICCs, the “SIC” protocol (Safe Insertion of Central
Catheters). It consists of seven different steps which
summarize those evidence-based recommendations that,
if applied correctly and systematically, allow to guaran-
tee a safe, successful, and cost-effective procedure
(Table 1).
Preprocedural evaluation: The rapid central
vein assessment (RaCeVA) and the central
zone insertion method (Central ZIM)
Proper pre-procedural evaluation obviously begins with an
adequate anamnestic evaluation. It is important to consider
whether the patients had previous vascular devices or
repeated difficult venipunctures. Also, it is important to
evaluate the patient’s coagulation and platelet status,
although the incidence of major bleeding complications
after central venous catheter placement is low, even in
coagulopathic patients.10
Before starting the procedure, two important issues of
concern are the selection of the appropriate vein and the
location of the exit site of the catheter.
The choice of the vein must be carefully considered
before proceeding with CICC insertion. The preference or
personal experience of the operator should not be consid-
ered as adequate criteria, as they do not guarantee maximal
safety for the patient. On the contrary, a rational and objec-
tive systematic evaluation of the anatomical characteristics
of the vascular system of each patient is possible through
adoption of a pre-procedural ultrasound scan of the ana-
tomical area in which the central venous access device will
be inserted.11
The Rapid Central Vein Assessment (RaCeVA) proto-
col is a systematic approach of US evaluation of the veins
of the neck and of the supra/infraclavicular area before
CICC insertion.12 RaCeVA follows a series of steps that
can be performed in a short time, and should always be
performed bilaterally. The RaCeVA is designed for an
easy, rapid, and systematic assessment of the six central
veins that can be theoretically punctured and cannulated
by US in the supra/infraclavicular area: internal jugular
vein (IJV), external jugular vein (EJV), brachiocephalic
vein (BCV), and subclavian vein (SV) in the supraclavicu-
lar area; axillary vein (AV) and cephalic vein (CV) in the
infraclavicular area. During the RaCeVA, the operator can
rule out venous abnormalities such as thrombosis, steno-
sis, external compression, anatomical variations of size
and shape of the veins, choose an appropriate catheter/vein
(ideal 1:3 or less) so to reduce the risk of catheter-related
thrombosis, and obtain a full anatomic evaluation for opti-
mum site selection and the best insertion approach for each
patient.2,12,13 Also, RaCeVA visualizes the surrounding
arterial or nervous structures that could be accidentally
injured during venous catheterization.12 The seventh and
last step of RaCeVA involves the assessment of pleural
space in the pre-insertion phase, providing an accurate
baseline assessment of pleural function prior to the inser-
tion of a CICC.12 This protocol is useful for teaching the
Table 1. The seven steps of the SIC protocol.
Step 1 Preprocedural evaluation—choice of the vein by systematic ultrasound examination of the veins of the neck and of the
supra/infraclavicular region (RaCeVA protocol) and choice of the ideal exit site (Central ZIM)
Step 2 Appropriate aseptic technique—hand hygiene, skin antisepsis with 2% chlorhexidine in 70% alcohol, maximal barrier
precautions
Step 3 Ultrasound-guided insertion—ultrasound-guided venipuncture, ultrasound verification of the correct direction of the
guidewire (tip navigation) and of the absence of pneumothorax (pleural scan)
Step 4 Intra-procedural assessment of tip location—verification of the central position of the tip by intracavitary ECG and/or by
transthoracic echocardiography, using the “bubble test”
Step 5 Adequate protection of the exit site—reduction of the risk of bleeding and risk of contamination by sealing with
cyanoacrylate glue
Step 6 Proper securement of the catheter—stabilization of the catheter using skin-adhesive sutureless devices, transparent
dressing with integrated securement or subcutaneous anchorage
Step 7 Appropriate coverage of the exit site—use of semi-permeable transparent dressing, preferably with high breathability
Brescia et al. 3
different US-guided approaches to the central veins.
RaCeVA ensures the operator systematically considers all
possible venous options allowing the most appropriate
vein to be accessed while also maintaining the patient
safety benefits.
The risk of infection or dislodgment of a central venous
access also depends on the choice of the exit site. This pro-
tocol suggests the opportunity of applying Dawson’s14
Zone Insertion Method (ZIM) for Peripherally Inserted
Central Catheters (PICCs) to the cervico-thoracic region
(so called “Central ZIM”). As demonstrated in the arm, the
cervico-thoracic region can be divided into three different
zones, red, yellow, and green, that correspond to the neck,
supraclavicular and infraclavicular regions (Figure 1).
The red zone is an area with high bacterial contamina-
tion of the skin, due to the proximity of the oropharyngeal
secretions. It is also an area with a high risk of catheter
dislodgment because of the movements of the neck. For
this reason, the neck region is to be avoided both as a veni-
puncture site and as an exit site.
The yellow zone corresponds to the supraclavicular
area, where US-guided venipuncture of internal jugular,
external jugular, brachio-cephalic, or subclavian vein is
feasible. An exit site in the supraclavicular area is accept-
able but not always ideal.
The green zone corresponds to the infraclavicular area,
where US-guided venipuncture of axillary or cephalic vein
is usually feasible. An exit site in the infraclavicular area is
ideal because of the low bacterial contamination and the
low risk of dislodgment.
Therefore, an optimal venipuncture site may not corre-
spond to an ideal exit site (Figure 2(a) and (b)).
Tunneling is a strategy that enables movement of the
catheter away from an area at high risk of infection or dis-
lodgment toward a safer exit site, providing both an opti-
mal insertion site and an optimal location of the exit site.15
As regards to CICC insertion, two main types of tunneling
are particularly useful: tunneling from the supraclavicular
area to the infraclavicular area (tunneling type A) (Figure
3(a)) and tunneling from the infraclavicular area to the
breast area (tunneling B) (Figure 3(b)). The latter might be
useful, for example, in patients with skin problems of the
chest area or in patients with tracheostomy (i.e. when it to
advisable to place the exit site as far as possible from res-
piratory or oral secretions).
For the tunneling of the catheter, it is preferable to use
blunt tunnelers, as they are associated with minimal risk of
local bleeding even in patients with coagulation disorders
or with reduced platelet counts.16
In short, RaCeVA permits clinicians to choose the opti-
mal venipuncture site while the Central ZIM compliments
RaCeVA to plan the optimal exit site.
Appropriate aseptic technique
The second very important step concerns the aseptic tech-
nique to be used during the placement of a CICC. Hand
hygiene must be preferably performed with hydroalco-
holic gel. In special cases, or when the hands are visibly
dirty, the hydroalcoholic gel must be preceded by washing
with soap and water, according to current international
infection prevention guidelines. For skin antisepsis, 2%
chlorhexidine in 70% alcohol should be used: iodine povi-
done in alcohol has a role only in case of known allergy to
chlorhexidine. Regarding the antiseptic application tech-
nique, no clinical difference in microorganism reduction
between the concentric circle and the back-and-forth tech-
niques has been documented, both techniques should be
used equally on clean and healthy skin.17
As recommended by all current guidelines, the risk of
bacterial contamination must be reduced by adopting the
maximal barrier precautions, non-sterile cap, non-sterile
mask, sterile gown, sterile gloves, full-size sterile drape
over the patient, plus adequate sterile protection of the
ultrasound probe that is long enough to cover the probe
and the ultrasound wire.2,4,18,19
Ultrasound-guided insertion
Ultrasound-guided venipuncture is considered mandatory
for any central venous catheterization.1 In the supraclav-
icular area, the IJV can be accessed by ultrasound guid-
ance, preferably with vein visualization in short axis and
in-plane puncture, so as to minimize any risk of arterial
injury. Other possible approaches in the supraclavicular
are the ultrasound-guided venipuncture of BCV, SV, or
EJV, with vein visualization in long axis and in-plane
puncture.12
In the infraclavicular area, the axillary vein can be visu-
alized in short axis, in long axis, or in oblique axis. The
oblique axis view is obtained rotating the probe to almost
halfway between the short axis and the long axis view.
Figure 1. Central Zone Insertion Method.
4 The Journal of Vascular Access 00(0)
This oblique axis approach visualizes the axillary vein, the
axillary artery, the pleura, and the other surrounding struc-
tures, making possible to perform a safe in-plane puncture.
The oblique axis + in-plane technique combines the
advantages of the panoramic view with the optimal visu-
alization of the needle tip obtained by the in-plane
puncture.20,21
The authors recommend the use of a micro-introducer
kit consisting of a 21G echogenic needle (for minimally
invasive venipuncture), a 0.018 nitinol guidewire with
straight soft tip, and a micro-introducer/dilator allows a
less traumatic vein dilation.
Soon after the ultrasound-guided venipuncture, ultra-
sound should also be used for assessing the correct direc-
tion of the guidewire toward the SVC (ultrasound-based
“tip navigation,” by scanning the veins of the supraclavic-
ular area), and for ruling out pneumothorax, by detecting
the “sliding sign” in the pleural space or other ultrasound
signs that exclude the presence of pneumothorax such as
the “seashore sign” using M-mode.13,22 Both maneuvers
can be performed with the same linear probe used for veni-
puncture. Assessment of the absence of ultrasound signs
suggestive of pneumothorax should be performed after
any central venipuncture.12
Intra-procedural assessment of tip location
The fourth important step of the SIC bundle is the intraproce-
dural assessment of the central position of the tip (“tip loca-
tion”). Post-procedural control of tip location is discouraged
by current guidelines,4 as it is associated with inefficiencies in
procedural time and resources, as well as potential harm to
the patient. The most cost-effective and accurate intra-proce-
dural method for tip location is intracavitary ECG.23
Fluoroscopy is an acceptable intra-procedural method, but is
often inaccurate, expensive, logistically difficult, and even
unsafe as it exposes patients and operators to ionizing radia-
tion.4 The applicability of the intracavitary ECG method has
also been extended more recently to atrial fibrillation
patients.24 Intracavitary ECG has some limitations of applica-
bility, for example in those situations in which the patient has
no atrial fibrillation, but the P wave is nonetheless not evident,
because of a pacemaker or some other abnormalities of car-
diac rhythm. In these cases, another effective, inexpensive,
Figure 3. (a) Tunneling of from supraclavicular area to infraclavicular area (b) Tunneling of from infraclavicular area to breast area.
Figure 2. (a) Venipuncture site for US guided CICCs (b) Exit-site for US guided CICCs.
Brescia et al. 5
and non-invasive intraprocedural method for tip location is
transthoracic echocardiography using the “bubble test” (a
rapid infusion of a few milliliters of “agitated” saline solution
that allows for better visualization of the catheter tip).1,13,25,26
Adequate protection of the exit site
The choice of an adequate exit site constitutes the first part of
a series of actions that make it possible to protect it. Tunneling
is a fundamental technique that allows to choose the appro-
priate exit site and the most suitable venipuncture site.4
At the time of CICC insertion, the best protection of the
exit site from bleeding and from extraluminal bacterial con-
tamination is the sealing with a cyanoacrylate glue. In addi-
tion, glue may reduce “micro-movements” of the catheter at
the exit site, reducing local damage to the endothelium of
the vein, potentially reducing the risk of intravenous throm-
bus formation.27 Gilardi et al.28 recommend using glue only
at the time of insertion; at the first dressing change, antibac-
terial protection of the exit site will be ensured using chlo-
rhexidine-impregnated sponge dressing. In the case of
tunneling, glue will also be used for closing the skin at the
site of venipuncture and tunneling puncture points.
Proper securement of the catheter
Securement by sutures is discouraged by all current
guidelines.3,4,6,19 Suture-based securement of venous access
devices is associated with high risk of exit site infection and
catheter dislodgment, as well as risk of accidental needle-
stick puncture for the operator. Current alternative options
for securement are skin-adhesive sutureless devices, trans-
parent dressing with integrated securement, and subcutane-
ous anchorage. In any patients at high risk for catheter
dislodgment (non-collaborative patients, skin abnormalities,
relevant perspiration, others) it is preferable to use a subcuta-
neously anchored sutureless device.29,30 Subcutaneously
anchored securement is safer and more effective than skin-
adhesive devices. It is also theoretically associated with less
risk of infection, since it allows more complete skin antisep-
sis around the exit site.29–32
Exit site coverage
The exit site should always be covered with a semi-perme-
able transparent dressing—preferably with a high breatha-
bility factor—so to ensure adequate protection of the exit
site and stabilization of the catheter. Appropriate catheter
securement and appropriate protection of the exit site are
key factors for reducing the incidence of dislodgment,
infection, and venous thrombosis.3,4
Conclusions
When placing a CICC, a certain number of evidence-based
strategies will protect against the risk of insertion-related
complications, either immediate (puncture failure, arterial
injury, hematoma, nerve injury, pneumothorax, hemotho-
rax, others) or early (arrhythmias, dislodgment, tip malpo-
sition, others) or late (infection, venous thrombosis,
others). These safe and beneficial strategies include the
use of ultrasound in different phases of the maneuver
(choice of the vein, venipuncture, tip navigation, tip loca-
tion, others), the adoption of standardized protocols for
choosing the vein (RaCeVA) and the exit site (Central
ZIM), the adoption of proper measures for infection pre-
vention (hand hygiene, skin antisepsis with 2% chlorhex-
idine in alcohol, maximal barrier precautions), the
preferential use of intracavitary ECG for catheter tip loca-
tion, and an appropriate protocol for sutureless securement
and exit site protection. In this regard, the adoption of
cyanoacrylate glue and subcutaneously anchored suture-
less device may be a perfect combination in terms of
cost-effectiveness.
Many complications, even some late complications, are
caused by wrong choices at the time of insertion. For
example, avoidance of ultrasound-guided venipuncture
may increase the risk of accidental arterial puncture and
pneumothorax. Failure to verify the proper location of the
tip may increase the risk of venous thrombosis. The choice
of a suboptimal exit site may expose the device to bacterial
contamination increasing the infectious risk.1–8 The use of
a standardized, systematic protocol—such as the one
described here—may improve the performance of CICC
insertion. The consistent and systematic adoption of all
seven recommendations of the SIC protocol will help to
save time and resources, safeguarding patient safety, and
ensuring cost-effectiveness.
Declaration of conflicting interests
The author(s) declared no potential conflicts of interest with
respect to the research, authorship, and/or publication of this
article.
Funding
The author(s) received no financial support for the research,
authorship, and/or publication of this article.
ORCID iDs
Fabrizio Brescia https://orcid.org/0000-0002-6892-474X
Mauro Pittiruti https://orcid.org/0000-0002-2225-7654
Matthew Ostroff https://orcid.org/0000-0001-5417-5621
Timothy R Spencer https://orcid.org/0000-0002-3128-2034
References
1. Lamperti M, Biasucci DG, Disma N, et al. European
Society of Anaesthesiology guidelines on peri-operative use
of ultrasound-guided for vascular access (PERSEUS vascu-
lar access). Eur J Anaesthesiol 2020; 37(5): 344–376.
2. Lamperti M, Bodenham AR, Pittiruti M, et al. International
evidence-based recommendations on ultrasound-guided
6 The Journal of Vascular Access 00(0)
vascular access. Intensive Care Med 2012; 38(7): 1105–
1117.
3. Pittiruti M, Hamilton H, Biffi R, et al. ESPEN guidelines on
parenteral nutrition: central venous catheters (access, care,
diagnosis and therapy of complications). Clin Nutr 2009;
28(4): 365–377.
4. Gorski L, Hadaway L, Hagle M, et al. Infusion therapy
standards of practice. J Infus Nurs 2021; 44(Suppl. 1): S1–
S224.
5. Moureau N, Lamperti M, Kelly LJ, et al. Evidence-based
consensus on the insertion of central venous access devices:
definition of minimal requirements for training. Br J
Anaesth 2013; 110(3): 347–356.
6. Bodenham A, Babu S, Bennett J, et al. Association of anaes-
thetists of Great Britain and Ireland: safe vascular access
2016. Anaesthesia 2016; 71(5): 573–585.
7. Bouaziz H, Zetlaoui PJ, Pierre S, et al. Guidelines on the
use of ultrasound guidance for vascular access. Anaesth Crit
Care Pain Med 2015; 34(1): 65–69.
8. Wu SY, Ling Q, Cao LH, et al. Real-time two-dimensional
ultrasound guidance for central venous cannulation: a meta-
analysis. Anesthesiology 2013; 118(2): 361–375.
9. Emoli A, Cappuccio S, Marche B, et al. The ISP (safe inser-
tion of PICCs) protocol: a bundle of 8 recommendations
to minimize the complications related to the peripherally
inserted central venous catheters (PICC). Assist Inferm Ric
2014; 33(2): 82–89.
10. van de Weerdt EK, Biemond BJ, Baake B, et al. Central
venous catheter placement in coagulopathic patients:
risk factors and incidence of bleeding complications.
Transfusion 2017; 57(10): 2512–2525.
11. Brescia F, Pittiruti M, Ostroff M, et al. Rapid Femoral Vein
Assessment (RaFeVA): a systematic protocol for ultra-
sound evaluation of the veins of the lower limb, so to opti-
mize the insertion of femorally inserted central catheters. J
Vasc Access. Epub ahead of print 16 October 2020. DOI:
10.1177/1129729820965063.
12. Spencer TR and Pittiruti M. Rapid Central Vein Assessment
(RaCeVA): a systematic, standardized approach for ultra-
sound assessment before central venous catheterization. J
Vasc Access 2019; 20(3): 239–249.
13. Biasucci DG. Ultrasound based innovations for interven-
tional procedures: the paradigmatic case of central venous
access. Minerva Anestesiol 2020; 86(2): 121–123.
14. Dawson R. PICC Zone Insertion Method™ (ZIM™): a sys-
tematic approach to determine the ideal insertion site for PICCs
in the upper arm. J Assoc Vasc Access 2011; 16 (3): 156–165.
15. Ostroff MD and Pittiruti M. Alternative exit sites for central
venous access: back tunneling to the scapular region and dis-
tal tunneling to the patellar region. J Vasc Access. Epub ahead
of print 9 July 2020. DOI: 10.1177/1129729820940178.
16. Giustivi D, Gidaro A, Baroni M, et al. Tunneling technique
of PICCs and midline catheters. J Vasc Access. Epub ahead
of print 16 March 2021. DOI: 10.1177/11297298211002579.
17. Carre Y, Moal B, Germain C, et al. Randomized study of
antiseptic application technique in healthy volunteers before
vascular access insertion (TApAS trial). J Infect 2020;
81(4): 532–539.
18. Loveday HP, Wilson JA, Pratt RJ, et al. UK Department
of Health. Epic3: national evidence-based guidelines for
preventing healthcare-associated infections in NHS hospi-
tals in England. J Hosp Infect 2014; 86(Suppl. 1): S1–S70.
19. O’Grady NP, Alexander M, Burns LA, et al. Healthcare
Infection Control Practices Advisory Committee (HICPAC).
Guidelines for the prevention of intravascular catheter-
related infections. Clin Infect Dis 2011; 52(9): e162–e193.
20. Biasucci DG, La Greca A, Scoppettuolo G, et al. Ultrasound-
guided central venous catheterization: it is high time to use
a correct terminology. Crit Care Med 2015; 43(9): e394–
e396.
21. Brescia F, Biasucci DG, Fabiani F, et al. A novel ultra-
sound-guided approach to the axillary vein: oblique-axis
view combined with in-plane puncture. J Vasc Access 2019;
20(6): 763–768.
22. Husain LF, Hagopian L, Wayman D, et al. Sonographic
diagnosis of pneumothorax. J Emerg Trauma Shock 2012;
5(1): 76–81.
23. Pittiruti M, Pelagatti F and Pinelli F. Intracavitary electro-
cardiography for tip location during central venous cathe-
terization: a narrative review of 70 years of clinical studies.
J Vasc Access. Epub ahead of print 24 June 2020. DOI:
10.1177/1129729820929835.
24. Calabrese M, Montini L, Arlotta G, et al. A modified intra-
cavitary electrocardiographic method for detecting the loca-
tion of the tip of central venous catheters in atrial fibrillation
patients. J Vasc Access 2019; 20(5): 516–523.
25. Iacobone E, Elisei D, Gattari D, et al. Transthoracic echo-
cardiography as bedside technique to verify tip location of
central venous catheters in patients with atrial arrhythmia. J
Vasc Access 2020; 21(6): 861–867.
26. Biasucci DG, La Greca A, Scoppettuolo G, et al. What’s
really new in the field of vascular access? Towards a global
use of ultrasound. Intensive Care Med 2015; 41(4): 731–733.
27. Scoppettuolo G, Dolcetti L, Emoli A, et al. Further benefits
of cyanoacrylate glue for central venous catheterisation.
Anaesthesia 2015; 70(6): 758.
28. Gilardi E, Piano A, Chellini P, et al. Reduction of bacte-
rial colonization at the exit site of peripherally inserted
central catheters: a comparison between chlorhexidine-
releasing sponge dressings and cyano-acrylate. J Vasc
Access. Epub ahead of print 4 September 2020. DOI:
10.1177/1129729820954743.
29. Pinelli F, Pittiruti M, Van Boxtel T, et al. GAVeCeLT-
WoCoVA consensus on subcutaneously anchored secure-
ment devices for the securement of venous catheters:
current evidence and recommendations for future research.
J Vasc Access. Epub ahead of print 2 July 2020. DOI:
10.1177/1129729820924568.
30. Pittiruti M, Pinelli F and GAVeCeLT Working Group for
Vascular Access in COVID-19. Recommendations for the
use of vascular access in the COVID-19 patients: an Italian
perspective. Crit Care 2020; 24(1): 269.
31. Rowe MS, Arnold K and Spencer TR. Catheter securement
impact on PICC-related CLABSI: a university hospital per-
spective. Am J Infect Control 2020; 48(12): 1497–1500.
32. Brescia F, Pittiruti M, Roveredo L, et al. Subcutaneously
anchored securement for peripherally inserted central
catheters: immediate, early, and late complications. J
Vasc Access. Epub ahead of print 17 June 2021. DOI:
10.1177/11297298211025430.
... [10][11][12][13][14] Over the last 20 years, The GAVeCeLT (the Italian Group of Long-Term Venous Access Devices) has developed many protocols and bundles-based on the current best available evidence-so to standardize different venous access procedures. Specific bundles have been proposed for the insertion of Centrally Inserted Central Catheters (CICCs), 15 of Femorally Inserted Central Catheters (FICCs) 16 and of PICCs. 17,18 The aim of this paper is to present a novel insertion protocol for PICC-port, nicknamed "Safe Insertion of PICC-Port (SIP-Port)." ...
... The most appropriate vein for cannulation should be chosen after a systematic ultrasound evaluation of the deep veins of the arm. [15][16][17][18]20,21 In this regard, we suggest using the same protocol adopted before PICC insertion, the Rapid Peripheral Vein Assessment (RaPeVA): this is a systematic ultrasound evaluation of the veins of the arms and of the cervico-thoracic area (bilaterally), and it has been previously described. 17,18 Ultrasound assessment of the superficial and deep veins of the forearm and arm is performed using a 7-12 MHz linear transducer. ...
... [26][27][28][29] These three cornerstones of infection prevention during insertion of venous access devices are the same recommended in the other insertion bundles developed by GAVeCeLT. [15][16][17][18] ...
Article
Full-text available
In the last decade, a new type of brachial port has been introduced in clinical practice, the so-called “PICC-port.” This is a brachial port, but inserted according to the methodologies and technologies currently adopted for the insertion of peripherally inserted central catheters (PICCs). Several studies have shown that PICC-port insertion is safe, not associated with any relevant immediate or early complication, and that the expected incidence of late complications is significantly lower if compared to “traditional” brachial ports (i.e. inserted without ultrasound guidance). Furthermore, PICC-ports yield excellent esthetic results and are associated with optimal patient compliance. This paper describes an insertion bundle—developed by GAVeCeLT, the Italian Group of Long Term Venous Access Devices, and nicknamed “SIP-Port” (Safe Insertion of PICC-Ports)—which consists of few evidence-based strategies aiming to further minimize all immediate, early, or late complications potentially associated with PICC-port insertion. Also, this insertion bundle has been developed for the purpose of defining more closely the differences between a traditional brachial port and a PICC-port. The SIP-Port bundle is currently adopted by all training courses on PICC-port insertion held by GAVeCeLT. It includes eight steps: (1) preprocedural ultrasound assessment utilizing the RaPeVA (Rapid Peripheral Venous Assessment) protocol; (2) appropriate skin antiseptic technique and maximal barrier precautions; (3) choice of appropriate vein, in terms of caliber and site; (4) clear identification of the median nerve and of the brachial artery during the venipuncture; (5) ultrasound-guided puncture and cannulation of the vein; (6) ultrasound-guided tip navigation; (7) intra-procedural assessment of tip location by intracavitary ECG or by trans-thoracic echocardiography; (8) appropriate creation and closure of the subcutaneous pocket.
... The purpose of a bundle focused on UVC insertion is to minimize any complication directly or indirectly related to the maneuver. A similar insertion bundle has already been proposed for the insertion of US-guided central venous access devices in neonates (the so called "SIC-Ped" bundle), [9][10][11] but it has never been developed before for UVCs. ...
... Insertion bundles have been developed for many central venous access devices inserted in different population of patients. 10,11,26 As far as we know, this is the first structured proposal of an insertion bundle for placement of UVC, consisting in a small number of evidence-based strategies apt to protect the patient from the risk of early complications (primary malposition) and late complications (dislodgment, tip malposition, infection, venous thrombosis, hepatic lesions, others). Such strategies include US (pre-procedural, intraprocedural, and post-procedural), the proper measures for infection prevention (hand hygiene, skin antisepsis with 2% chlorhexidine in alcohol, maximal barrier precautions), and an appropriate protocol for catheter securement (including cyanoacrylate glue and transparent membranes with high moisture vapor transmission rate). ...
Article
Insertion of umbilical venous catheters is a common procedure in neonatal intensive care. Though sometimes lifesaving, this maneuver is potentially associated with early and late complications, some of which may be severe and even life threatening (catheter malposition, hepatic lesions, venous thrombosis, pericardial effusion, etc.). The recent literature suggests several operative strategies that, if adopted systematically, may significantly reduce the incidence of both early and late catheter related complications. This paper describes a standardized protocol (Safe Insertion Umbilical Venous Catheter = SIUVeC) which incorporates such novel strategies, with the goal of minimizing the complications related to this procedure.
... 5 Although protocols like RaCeVa (Rapid Central Vein Assessment) and SIC (Safe Insertion of Centrally Inserted Central Catheters) have been proposed to enhance the efficacy and safety of central vein catheterization, guidewire loss remains a significant issue that has not been mitigated by the implementation of these new protocols. 3,6,7 Guidewire loss is a very rare complication of central venous catheterization (CVC), typically considered a "never event", but it still occurs at a frequency of 0.05%. 3 Complete loss of the guidewire is usually asymptomatic, as observed in this case, but can lead to fatal complications, such as cardiac tamponade, blood vessel perforation, and dysrhythmia. ...
Article
Full-text available
Guidewire loss is a rare complication of central venous catheterization. A 65-year-old male was hospitalized in a high-dependency unit for exacerbation of chronic obstructive pulmonary disease, pneumonia, erythrocytosis, and clinical signs of heart failure. Upon admission, after an unsuccessful right jugular approach, a left jugular central venous catheter was placed. The next day, chest radiography revealed the catheter located in the left parasternal region, with suspected retention of the guidewire, visually confirmed by the presence of its proximal end inside the catheter. The left parasternal location of the catheter and the typical projection of the guidewire in the coronary sinus, later confirmed by echocardiography, raised suspicion of a persistent left superior vena cava (PLSVC). Agitated saline injected into the left antecubital vein confirmed bubble entry from the coronary sinus into the right atrium. After clamping the guidewire, the catheter was carefully retrieved along with the guidewire without any complications. This is the first reported case of guidewire retention in PLSVC and coronary sinus. It underscores the potential causes of guidewire loss and advocates preventive measures to avoid this potentially fatal complication.
... Insertion bundles have been developed for many CVADs inserted in different population of patients. 10,[40][41][42] As far as we know, this is the first structured proposal of an insertion bundle for placement of ECC. ...
Article
Epicutaneo-cava catheters are the most widely used central venous catheters in the neonate, but their insertion and management are potentially associated with several complications, both during placement (failure to proceed with the catheter, primary malposition, etc.) and during maintenance (infection, venous thrombosis, catheter dislocation, secondary malposition, etc.). Recent studies have identified methods and techniques that may be effective in minimizing the risk of most of these complications. This paper proposes a structured, sequential insertion bundle—nicknamed “the SIECC protocol” (SIECC = Safe Insertion of Epicutaneo-Cava Catheters)—which includes seven evidence-based strategies which have been proven to increase the safety, effectiveness, and cost-effectiveness of the procedure.
... New generation polyurethane catheters, either 3Fr single lumen or 4Fr double lumen, were placed according to our insertion bundle for neonatal central lines which has been published elsewhere [21][22][23] and has been summarized in Table 1. ...
Article
Full-text available
Critically ill newborns admitted to Neonatal Intensive Care Unit often require a centrally inserted central catheters (CICCs) inserted by ultrasound-guided puncture of the internal jugular or brachio-cephalic vein. Achieving an appropriate level of sedation and analgesia is paramount for procedure success and patient safety, avoiding the potential risks associated with excessive deep sedation. The aim of this study is to evaluate the feasibility of a novel protocol of sedation. Data from 46 patients were prospectively collected. The feasibility was assessed throughout the monitoring of adverse events and the incidence of spontaneous movements. The procedure was completed in 100% of cases. There were no cases of escalation of the baseline ventilatory support despite the procedure and no case of hypotension, and all spontaneous movements were controlled with additional boluses when required. Conclusion: Our study represents the very first step towards the design of a validated protocol for analgosedation during ultrasound-guided CICC insertion in NICU. What is Known: • Critically ill newborns admitted to Neonatal Intensive Care Unit often require a centrally inserted central catheter. • Achieving an appropriate level of sedation and analgesia is paramount for procedure success and patient safety, avoiding the potential risks associated with excessive deep sedation. What is New: • The use of this new protocol for analgosedation is able to achieve a good level of sedation and pain control without significant adverse event. • Ultrasound-guided CICC insertion can be performed even in non-ventilated newborns.
... Correct tip placement of central venous access devices (CVAD) is crucial during insertion. [1][2][3][4] Malposition of the catheter's tip can lead to life-threatening mechanical complications, such as thrombosis, vessel wall erosion, and CVAD malfunction. 5 In the first decade of the 21st century, intracavitary electrocardiography (IC-ECG) has exponentially grown, 6 as a time-saving intra-procedural technique, enabling immediate use of the CVAD. ...
Article
Full-text available
Introduction Intraprocedural tip control techniques are critical during central venous catheter placement. According to international guidelines (INS 2021), intracavitary electrocardiography is the first method of choice to verify it; when this technique is not feasible, it is considered acceptable to use a contrast-enhanced ultrasound-based tip location method, commonly known as “bubble-test” as an effective alternative. Objective To assess whether the length of the vascular catheter can alter the time between the injection of the contrast media and its appearance at the catheter tip and the injection duration. Differences between operators stratified according to experience were evaluated as secondary endpoints. Methods A bench study was conducted using an extracorporeal circuit. For each catheter length (60, 40, and 20 cm), three injections were obtained by each of the five operators with different levels of experience for a total of 45 measurements. Differences among operators were evaluated using ANOVA, and the impact of catheter length and operator expertise on times was assessed using repeated measurement models. Results Hub-to-tip times of 247.33 ms (SD 168.82), 166 ms (SD 95.46), 138 ms (SD 54.48), and injection duration of 1620 ms (SD 748.58), 1614 ms (SD 570.95), 1566 ms (SD 302.83) were observed for 60, 40, 20 cm catheter length, respectively. A significant time variability between operators was observed. Moreover, moving from 60 to 20 cm, hub-to-tip time was significantly longer for 60 cm devices ( p = 0.0124), while little differences were observed for injection duration. Conclusions Catheter length can change both the time between the injection of the contrast media and its appearance at the catheter tip and the injection duration. Hub-to-tip times obtained with 20 and 40 cm and overall injection duration did not differ significantly; skilled personnel could substantially reduce both values analyzed in this study.
... Correct tip placement of central venous access devices (CVAD) is crucial during insertion. [1][2][3][4] Malposition of the catheter's tip can lead to life-threatening mechanical complications, such as thrombosis, vessel wall erosion, and CVAD malfunction. 5 In the first decade of the 21st century, intracavitary electrocardiography (IC-ECG) has exponentially grown, 6 as a time-saving intra-procedural technique, enabling immediate use of the CVAD. ...
Article
Introduction: Intraprocedural tip control techniques are critical during central venous catheter placement. According to international guidelines (INS 2021), intracavitary electrocardiography is the first method of choice to verify it; when this technique is not feasible, it is considered acceptable to use a contrast-enhanced ultrasound-based tip location method, commonly known as "bubble-test" as an effective alternative. Objective: To assess whether the length of the vascular catheter can alter the time between the injection of the contrast media and its appearance at the catheter tip and the injection duration. Differences between operators stratified according to experience were evaluated as secondary endpoints. Methods: A bench study was conducted using an extracorporeal circuit. For each catheter length (60, 40, and 20 cm), three injections were obtained by each of the five operators with different levels of experience for a total of 45 measurements. Differences among operators were evaluated using ANOVA, and the impact of catheter length and operator expertise on times was assessed using repeated measurement models. Results: Hub-to-tip times of 247.33 ms (SD 168.82), 166 ms (SD 95.46), 138 ms (SD 54.48), and injection duration of 1620 ms (SD 748.58), 1614 ms (SD 570.95), 1566 ms (SD 302.83) were observed for 60, 40, 20 cm catheter length, respectively. A significant time variability between operators was observed. Moreover, moving from 60 to 20 cm, hub-to-tip time was significantly longer for 60 cm devices (p = 0.0124), while little differences were observed for injection duration. Conclusions: Catheter length can change both the time between the injection of the contrast media and its appearance at the catheter tip and the injection duration. Hub-to-tip times obtained with 20 and 40 cm and overall injection duration did not differ significantly; skilled personnel could substantially reduce both values analyzed in this study.
Article
Full-text available
Objectives To compare catheter-related outcomes of individuals who received a tunnelled femorally inserted central catheter (tFICC) with those who received a peripherally inserted central catheter (PICC) in the upper extremities. Design A propensity-score matched cohort study. Setting A 980-bed tertiary referral hospital in South West Sydney, Australia. Participants In-patients referred to the hospital central venous access service for the insertion of a central venous access device. Primary and secondary outcome measures The primary outcome of interest was the incidence of all-cause catheter failure. Secondary outcomes included the rates of catheters removed because of suspected or confirmed catheter-associated infection, catheter dwell and confirmed upper or lower extremity deep vein thrombosis (DVT). Results The overall rate of all-cause catheter failure in the matched tFICC and PICC cohort was 2.4/1000 catheter days (95% CI 1.1 to 4.4) and 3.0/1000 catheter days (95% CI 2.3 to 3.9), respectively, and when compared, no difference was observed (difference −0.63/1000 catheter days, 95% CI −2.32 to 1.06). We found no differences in catheter dwell (mean difference of 14.2 days, 95% CI −6.6 to 35.0, p=0.910); or in the cumulative probability of failure between the two groups within the first month of dwell (p=0.358). No significant differences were observed in the rate of catheters requiring removal for confirmed central line-associated bloodstream infection (difference 0.13/1000 catheter day, 95% CI −0.36 to 0.63, p=0.896). Similarly, no significant differences were found between the groups for confirmed catheter-related DVT (difference −0.11 per 1000 catheter days, 95% CI −0.26 to 0.04, p=1.00). Conclusion There were no differences in catheter-related outcomes between the matched cohort of tFICC and PICC patients, suggesting that tFICCs are a possible alternative for vascular access when the veins of the upper extremities or thoracic region are not viable for catheterisation.
Article
Implantation of centrally inserted central venous catheter (CICC) may be complicated by bleedings particularly in patients with severe coagulopathy or taking antithrombotic drugs. It has been shown that the application of the Italian Group for Venous Access Devices (GAVeCeLT) bundle reduces the incidence of bleeding in patients admitted to intensive care units (ICU), but its effectiveness has never been demonstrated in different contexts. In this study we evaluated the incidence of bleeding after urgent internal jugular CICC (J-CICC) implantation in patients with increased or no risk of bleeding complications when recommended preventive strategies are applied systematically. We included 185 patients admitted to Internal Medicine Units who underwent urgent J-CICC implantation from April 2016 to December 2018. The incidence of major and minor bleeding immediately after the procedure and in the following 30 days was recorded. None of the enrolled patients showed major bleeding. The incidence of minor bleedings was 2.1% (95% IC: 0.03–4.2) with two patients requiring line removal and repositioning (1.1%; 95% IC: −0.45 to 2.6). Bleeds were not correlated with age or sex, although they all occurred in female subjects. The incidence of bleeds was not increased in patients with increased risk of bleeding compared with those without (5.0% vs 1.3%; p = 0.16). The use of anti-thrombotic medications was significantly associated with increased risk of minor bleedings ( p = 0.03). In this study we demonstrated that the application of the GAVeCeLT suggested bundle can minimize the number of bleeding complications even in patients hospitalized in Internal Medicine Units. Further data are needed in patients taking antithrombotic drugs who appear to be more prone to minor bleeding, however the benefit of completing the procedure appears to significantly outweigh the risk of mechanical complications.
Article
Full-text available
Background The tunneling technique is currently widely used for placement of CVC. Recently, some clinicians have used this technique for peripherally inserted central catheters (PICC), or Midline catheters (MCs). Objective To describe a safe antegrade tunneling technique for PICCs and MCs insertion with a blunt tunneler. Methods This retrospective monocentric survey collected ASST Lodi hospital data from January 1st to December 31st, 2019. The indication for PICCs and MCs tunneled implant was to respect the correct vein/catheter ratio or special clinical situation (children, burns, wounds, and wider catheter 5/6 fr). Contraindications included the operator’s low skills and severe risk of bleeding (INR > 3; Platelet count <50’000). Results About 390 PICCs (327 4 fr and 63 5 fr) and 183 MCs were placed. One hundred and sixty-five PICCs (42%) and 110 MCs (60%) were tunneled. Five fr PICCs were more present among tunneled catheters (54/165 [32.7%] vs 9/225 [4%] p < 0.0001). In the majority tunneling was necessary to respect the correct catheter/vein ratio. The exit site was shifted only for four special clinical situations: skin infections (one PICC and two MCs); burns (one MC). No early complication (intraprocedural, major bleeding), catheter related thrombosis, or device fractures occurred. Two catheter-related bloodstream infections (one PICC, one MC), nine dislocations (four PICCs, five MCs), one MC occlusion were recorded. Conclusions The antegrade tunneling technique with blunt tunneler of PICCs and MCs is simple, rapid and is regarded as a safe maneuver. More in-depth and future prospective studies are needed to evaluate the impact of tunneling on early and late complications.
Article
Full-text available
Background In France about 32% of hospitalized patients have a vascular access placement. However, a common complication associated with these is catheter-related bloodstream infection (CRBI) due to the introduction of microorganisms from the skin during catheter insertion. There is no consensus on the best way to clean the skin prior to catheter insertion, which could be a key element of CRBI prevention. The two techniques most commonly used to apply antiseptic to the skin are the concentric circle and back-and-forth techniques, but these have not been compared in clinical trials. Hence, this study conducted this comparison. Methods This single-center, non-comparative, randomized, matched pilot study investigated the levels of cutaneous microorganisms before and after antiseptic application using both techniques in a population of healthy French volunteers. The two application methods were used on each participant's arms at the elbow fold, with randomization for the application side (right or left). Quantification of cutaneous microorganisms was performed in a blinded manner with regard to the technique used. Findings From April 8 to July 17, 2019, 132 healthy volunteers participated in the study. For the whole study population, the mean initial colonization level was 2.68 log10 colony forming units (CFU)/mL (SD 0.82) before the back-and-forth technique, and 2.66 log10 CFU/mL (SD 0.85) before the concentric circle technique. The mean differences in number of microorganisms between the initial sample and the final sample were 2.45 log10 CFU/mL (95% CI: 2.29 to 2.61) for the back-and-forth technique and 2.43 log10 CFU/mL (95% CI: 2.27 to 2.59) for the concentric circle technique. The mean difference in reduction in microorganisms between the back-and-forth technique and the concentric circle technique was 0.02 log10 CFU/mL (95% CI: –0.11 to 0.15). Interpretation There was no clinically difference in reduction of microorganisms between the concentric circle and back-and-forth techniques at the bend of the healthy volunteer's elbow, after the 30 seconds of drying of the antiseptic. These findings have a significant impact on time required to achieve antiseptic application before catheter insertion because there is yet no argument to justify application for 30 s, because a single concentric circle pass was much faster with similar results. Future studies should investigate the impact of skin application technique on the prevention of infectious risk associated with catheter insertion on admission to health care facilities (conventional, outpatient, or emergency) and throughout the period of stay in a health care facility.
Article
Full-text available
The use of a subcutaneous engineered securement device (SESD) for peripherally inserted central catheters (PICC) in an acute care setting was found to have a direct impact on central line associated bloodstream infection (CLABSI) rates compared to traditional adhesive engineered securement devices (AESD). Objective: While the literature suggests the use of SESDs has had successful results for device securement, it is unknown to what extent they may impact CLABSI rates. Securement and stabilization performance among devices may be a direct risk factor for CLABSIs. Methods: A retrospective quality review of 7,776 cases was conducted at a large academic medical center. The primary researcher implemented a quantitative design which was analysed with demographics statistics and relative risk ratio. Results: There was a 288% (n=47) increase in relative risk of CLABSI found in the AESD group compared to the SESD group. The results imply the use of SESDs may improve nursing practice and patient outcomes lowering CLABSI rates in patients with PICCs by a reduction of risks associated with securement design differences.
Article
Background An adequate stabilization of a vascular device is an important part of insertion bundles and is an effective strategy in reducing complications. Dislodgment has a relevant clinical impact and an increase in healthcare costs. Method We have retrospectively investigated the safety and efficacy of Subcutaneously Anchored Securement (SAS) for Peripherally Inserted Central Catheters (PICC) in cancer patients. Results We analyzed 639 patients who had a PICC inserted and secured with SAS, over the past 3 years (2018–2020). No immediate complications during SAS placement were reported. In the first 24–48 h, a slight local ecchymosis was reported in 24 cases with rapid spontaneous resolution. No cases of bleeding or hematoma of the exit site were reported. The total number of catheter days was 93078. Dislodgment occurred only in seven cases (1.1%). In 16 patients, the PICC was removed because of catheter-related bloodstream infection (CRBSI): the overall incidence of CRBSI was 0.17 per 1000 catheter days. Symptomatic venous thrombosis was documented in 12 patients (1.9%) and treated with low molecular weight heparin without PICC removal. We had no cases of irreversible lumen occlusion. In 17 patients, local discomfort—including device-related pressure ulcers and painful inflammation—was reported: these cases were treated without SAS removal or PICC removal. Conclusion In this retrospective analysis, subcutaneously anchored securement of PICCs was a safe and effective strategy for reducing the risk of dislodgment.
Article
In this paper we describe a new protocol—named RaFeVA (Rapid Femoral Vein Assessment)—for the systematic US assessment of the veins in the inguinal area and at mid-thigh, designed to evaluate patency and caliber of the common and superficial femoral veins and choose the best venipuncture site before insertion of a FICC.
Article
Introduction: A serious complication associated with Central Venous Access Device (CVAD) is infection because of bacterial contamination, either by the extra-luminal or by the intra-luminal route.We evaluated the efficacy, the safety, and the cost-effectiveness of two strategies for non-inferiority in controlling bacterial colonization of the exit-site of Peripherally-Inserted Central Catheters (PICC). Methods: After PICC placement, a skin swab of the exit site was taken and cultured. In group A the exit site was sealed with N-butyl-cyanoacrylate glue, while in group B a chlorhexidine-releasing sponge dressing was applied. A second skin culture was taken at day 7. Results: A total of 51 patients were enrolled in each group. In 42 patients the second skin culture was not performed because of 20 patients were lost at follow-up or deceased and in 22 patients the dressing needed to be changed early, because of local bleeding (13 cases, in group B) or because of dressing detachment (four in group A and five in group B). The microbiological study was completed in 36 patients in group A and 24 in group B. No microorganisms were isolated in any patient. Conclusions: Both strategies were effective in controlling bacterial colonization. Glue was effective in reducing local bleeding, and it was more cost-effective than sponge dressing. During the first week, when local bleeding and bacterial colonization must be prevented, glue might be more appropriate than chlorhexidine-releasing dressing; after the first week chlorhexidine-releasing dressing might be preferable, considering that the safety of glue application on the skin for prolonged periods is still questionable.
Article
Uncooperative elderly patients with cognitive disorder are often confused and/or agitated. Risk of involuntary venous access device dislodgment is high in these patients. This is equally likely with peripherally inserted central catheters and centrally inserted central catheters but less common with femorally inserted central catheters. Solutions to this problem include strict continuous patient observation, using sutures or subcutaneous anchored securement, wrapping the arm to “hide” the line, or using soft mittens to occupy the hands. However, some patients are able to disrupt the dressing, dislodge the catheter, and often pull the catheter out completely. In some cases, the patient may also overcome the resistance offered by the stitches or by the subcutaneous anchored securement device. In a recent paper on the impact of subcutaneously anchored securement in preventing dislodgment, the only demonstrated failures occurred in non-compliant elderly patients. Creation of an alternative exit site is an emerging trend in patients with cognitive impairment at high risk for catheter dislodgement. Subcutaneous tunneling from traditional insertion sites such as the jugular, axillary, or femoral veins allows placement of the exit site in a region inaccessible to the patient. The following two case reports demonstrate the technique for tunneling a femorally inserted central catheter downward to the patellar region and for tunneling a centrally inserted central catheter to the scapular region. Internal review board approval was not deemed necessary as subcutaneous tunneling is not a new technique. In our experience, such maneuvers can be successfully performed at the bedside.
Article
Background Subcutaneously anchored securement devices (or subcutaneous engineered securement devices) have been introduced recently into the clinical practice, but the number of published studies is still scarce. The Italian Group of Long-Term Central Venous Access Devices (GAVeCeLT)—in collaboration with WoCoVA (World Congress on Vascular Access)—has developed a Consensus about the effectiveness, safety, and cost-effectiveness of such devices. Methods After the definition of a panel of experts, a systematic collection and review of the literature on subcutaneously anchored securement devices was performed. The panel has been divided in two working groups, one focusing on adult patients and the other on children and neonates. Results Although the quality of evidence is generally poor, since it is based mainly on non-controlled prospective studies, the panel has concluded that subcutaneously anchored securement devices are overall effective in reducing the risk of dislodgment and they appear to be safe in all categories of patients, being associated only with rare and negligible local adverse effects; cost-effectiveness is demonstrated—or highly likely—in specific populations of patients with long-term venous access and/or at high risk of dislodgment. Conclusion Subcutaneously anchored securement is a very promising strategy for avoiding dislodgment. Further studies are warranted, in particular for the purpose of defining (a) the best management of the anchoring device so to avoid local problems, (b) the patient populations in which it may be considered highly cost-effective and even mandatory, (c) the possible benefit in terms of reduction of other catheter-related complications such as venous thrombosis and/or infection, and—last but not least—(d) their impact on the workload and stress level of nurses taking care of the devices.
Article
Intracavitary electrocardiography is an accurate and non-invasive method for central venous access tip location. Using the catheter as a traveling intracavitary electrode, intracavitary electrocardiography is based on the increase in the detected amplitude of the P wave while approaching the cavoatrial junction. Despite having been adopted diffusely in clinical practice only in the last years, this method is not novel. In fact, it has first been described in the late 40s, during electrophysiological studies. After a long period of quiescence, it is in the last two decades of the XX century that intracavitary electrocardiography became popular as an effective mean of central venous catheters tip location. But the golden age of this technique began with the new millennium, as documented by high-quality studies in this period. In fact, in those years, intracavitary electrocardiography has been studied broadly, and important achievements in terms of comprehension of the technique, accuracy, and feasibility of the method in different populations and conditions (i.e. pediatrics, renal patients, atrial fibrillation) have been gained. In this review, we describe the technique, its history, and its current perspectives.